Spirair
Spirair is a startup headquartered in South San Francisco, United States, founded in 2020. It has raised at least $24.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Spirair has raised at least $24.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Spirair sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in South San Francisco
- Addition Therapeutics
- Asher Biotherapeutics
- Burnbot
- Dualitas Therapeutics
- Firefly Bio
- Kamau Therapeutics
- Long Bridge Medical
- Lycia Therapeutics
- Mahzi Therapeutics
- Moonwalk Biosciences
- NewLimit
Related
- Innovation profile of South San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Spirair do?
Spirair is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Spirair raised?
At least $24.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Spirair based?
Spirair is headquartered in South San Francisco, United States.
When was Spirair founded?
Spirair was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.